Induction of Th1-biased cytokine production by  -carba-GalCer, a neoglycolipid ligand for NKT cells

T. Tashiro(Immune Regulation (United Kingdom)), Etsuko Sekine-Kondo(Immune Regulation (United Kingdom)), Tomokuni Shigeura(Immune Regulation (United Kingdom)), Ryusuke Nakagawa(Immune Regulation (United Kingdom)), Satoko Inoue(Immune Regulation (United Kingdom)), Miyuki Omori‐Miyake(Immune Regulation (United Kingdom)), Tomoki Chiba(Immune Regulation (United Kingdom)), Nobuko Hongo(Immune Regulation (United Kingdom)), Shin‐ichiro Fujii(RIKEN Center for Integrative Medical Sciences), Kazuo Shimizu(RIKEN Center for Integrative Medical Sciences), Yohei Yoshiga(University of Tsukuba), Takayuki Sumida(University of Tsukuba), Kenji Mori(Immune Regulation (United Kingdom)), Hiroshi Watarai(Immune Regulation (United Kingdom)), Mitsutaka Taniguchi(Immune Regulation (United Kingdom))
International Immunology
February 24, 2010
Cited by 38

Abstract

NKT cells are characterized by their production of both T(h)1 and T(h)2 cytokines immediately after stimulation with alpha-galactosylceramide (alpha-GalCer), which is composed of alpha-galactopyranose linked to ceramide (itself composed of sphingosine and fatty-acyl chains); the chain length of the ceramide varies and this affects the ability of alpha-GalCer to stimulate cytokine production. However, the contribution of its galactopyranose sugar moiety remains unclear. We synthesized alpha-carba-GalCer, which has an alpha-linked carba-galactosyl moiety; here, the 5a'-oxygen atom of the D-galactopyranose ring of alpha-GalCer is replaced by a methylene group. The alpha-carba-GalCer was more stable and showed higher affinity to the NKT receptor. It thus enhanced and prolonged production of IL-12 and IFN-gamma compared with alpha-GalCer, resulting in augmented NKT cell-mediated adjuvant effects in vivo. The alpha-carba-GalCer, which has an ether linkage, was more resistant to degradation by liver microsomes than was alpha-GalCer, which has an acetal bond. Modulation of the sugar moiety in glycolipids might therefore provide optimal therapeutic reagents for protective immune responses against tumor or pathogens.


Related Papers

No related papers found

Powered by citation graph analysis